Real‐world clinical experience in the Connect ® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres-Reference-Cited by-同舟云学术

Real‐world clinical experience in the Connect ® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres

Published:2016-11-08 Issue:5 Volume:175 Page:892-903
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mato Anthony¹,Nabhan Chadi²,Kay Neil E.³,Weiss Mark A.⁴,Lamanna Nicole⁵,Kipps Thomas J.⁶,Grinblatt David L.⁷,Flinn Ian W.⁸,Kozloff Mark F.⁹¹⁰,Flowers Christopher R.¹¹,Farber Charles M.¹²,Kiselev Pavel¹³,Swern Arlene S.¹³,Sullivan Kristen¹⁴,Flick E. Dawn¹⁵,Sharman Jeff P.¹⁶

Affiliation:

1. Center for CLL Abramson Cancer Center University of Pennsylvania Philadelphia PA USA

2. University of Chicago Chicago IL USA

3. Division of Hematology Mayo Clinic Rochester MN USA

4. Thomas Jefferson University Philadelphia PA USA

5. Leukemia Service Hematologic Malignancies Section Department of Medicine New York‐Presbyterian/Columbia University Medical Center New York NY USA

6. UCSD Moores Cancer Center La Jolla CA USA

7. NorthShore University Health System Evanston IL USA

8. Sarah Cannon Research Institute/Tennessee Oncology PLLC Nashville TN USA

9. Section of Oncology/Hematology Ingalls Hospital Harvey IL USA

10. Department of Medicine University of Chicago Chicago IL USA

11. Emory University Atlanta GA USA

12. Carol G. Simon Cancer Center Morristown Memorial Hospital Morristown NJ USA

13. Celgene Corporation Summit NJ USA

14. Celgene Corporation Overland Park KS USA

15. Celgene Corporation San Francisco CAUSA

16. Willamette Valley Cancer US Oncology Springfield OR USA

Funder

Celgene

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.14332

Reference36 articles.

1. The real world: CLL

2. Altekruse S.F. Kosary C.L. Krapcho M. Neyman N. Aminou R. Waldron W. Ruhl J. Howlader N. Tatalovich Z. Cho H. Mariotto A. Eisner M.P. Lewis D.R. Cronin K. Chen H.S. Feuer E.J. Stinchcomb D.G.&Edwards B.K.(eds). (2010)SEER Cancer Statistics Review 1975–2007. Available from:http://seer.cancer.gov/csr/1975_2007.htm[Accessed September 3 2015].

3. Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

4. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

5. CinicalTrials.gov.A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥ 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL). Available from:https://clinicaltrials.gov/ct2/show/NCT01886872[Accessed September 3 2015].

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Do We Manage Chronic Lymphocytic Leukemia in India;Current Hematologic Malignancy Reports;2024-02-01

2. Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study;Cancers;2023-08-10

3. Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases;Cancers;2023-08-08

4. Patterns of use of biological and genetic markers for chronic lymphocytic leukemia and acute myeloid leukemia in Puerto Rico;Cancer Medicine;2022-11-25

5. Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia;Current Medical Research and Opinion;2022-10-22